From July 16th to July 18th, the third session of the Boao Forum for Global Health was held at the National Convention Center in Beijing, China. This forum is an event within the framework of the Boao Forum for Global Health, co-hosted by the Boao Forum for Global Health and the People's Government of Beijing Municipality, organized by the Management Committee of Beijing Economic-Technological Development Area, and received strong support from the Chinese government of the host country, Chinese embassies in China, international organizations, multinational corporations, research institutions, and media.
As a strategic partner of the forum, Frost & Sullivan, in conjunction with the Organizing Committee of the Boao Forum on Global Health, officially released the 'Blue Book on the Current Development and Future Trends of AI Medical Imaging Industry' (hereinafter referred to as the 'Blue Book'). The aim is to systematically introduce and provide an in-depth interpretation of the AI medical imaging industry chain, industry pain points, policy supervision system, financing hotspots, driving factors, etc., and present a complete picture of its development and market landscape.
The 'Blue Book' will start with disease areas such as lungs, breast, cardiovascular and cerebrovascular diseases, orthopedics, and fundus diseases. It will delve into the research and development progress and commercialization of AI in various disease diagnoses, providing research guidance for market valuation, R&D assessment, capital dynamics, corporate strategy, etc.
